A replicon-based COVID-19 vaccine candidate delivered by tobacco mosaic virus-like particles. Karan S, Opdensteinen P, Ma Y, De Oliveira JFA, et al. Vaccine 2025;53:127063.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Karan S, Opdensteinen P, Ma Y, De Oliveira JFA, et al. A replicon-based COVID-19 vaccine candidate delivered by tobacco mosaic virus-like particles. Vaccine 2025;53:127063.
PMID: 40168732